0000000000542705

AUTHOR

Arutha Kulasinghe

0000-0003-3224-7350

showing 2 related works from this author

Emerging Standards and the Hybrid Model for Organizing Scientific Events During and After The COVID-19 Pandemic

2020

AbstractSince the beginning of 2020, the coronavirus disease (COVID-19) pandemic has dramatically influenced almost every aspect of human life. Activities requiring human gatherings have either been postponed, canceled, or held completely virtually. To supplement lack of in-person contact, people have increasingly turned to virtual settings online, advantages of which include increased inclusivity and accessibility and a reduced carbon footprint. However, emerging online technologies cannot fully replace in-person scientific events. In-person meetings are not susceptible to poor Internet connectivity problems, and they provide novel opportunities for socialization, creating new collaboratio…

business.product_categorySanitationCoronavirus disease 2019 (COVID-19)event1117 Public Health and Health ServicesConcepts in Disaster Medicine03 medical and health sciences0302 clinical medicineSDG 3 - Good Health and Well-beingPandemicInternet accessHumans030212 general & internal medicineResilience (network)resiliencePandemicsEventPandemicResilienceEvent (computing)business.industryStrategic Defence & Security StudiesSARS-CoV-2pandemicSocializationPublic Health Environmental and Occupational HealthCongressCOVID-19standardPublic relationsStandardcongressCarbon footprintBusinessDelivery of Health Care030217 neurology & neurosurgery
researchProduct

Flower lose, a cell fitness marker, predicts COVID‐19 prognosis

2021

Abstract Risk stratification of COVID‐19 patients is essential for pandemic management. Changes in the cell fitness marker, hFwe‐Lose, can precede the host immune response to infection, potentially making such a biomarker an earlier triage tool. Here, we evaluate whether hFwe‐Lose gene expression can outperform conventional methods in predicting outcomes (e.g., death and hospitalization) in COVID‐19 patients. We performed a post‐mortem examination of infected lung tissue in deceased COVID‐19 patients to determine hFwe‐Lose’s biological role in acute lung injury. We then performed an observational study (n = 283) to evaluate whether hFwe‐Lose expression (in nasopharyngeal samples) could accu…

OncologyMedicine (General)medicine.medical_specialtyFlowersDiseaseQH426-470Lung injurySeverity of Illness Indexcell fitnessArticleR5-920COVID‐19Internal medicineSeverity of illnessGeneticsmedicineHumansPandemicsRetrospective StudiesReceiver operating characteristicSARS-CoV-2business.industryCOVID-19Retrospective cohort studyArticlesTriageMicrobiology Virology & Host Pathogen InteractionflowerROC CurvebiomarkerMolecular MedicineBiomarker (medicine)Observational studyprognosisbusinessBiomarkersEMBO Molecular Medicine
researchProduct